JP2025160226A5 - - Google Patents
Info
- Publication number
- JP2025160226A5 JP2025160226A5 JP2025114854A JP2025114854A JP2025160226A5 JP 2025160226 A5 JP2025160226 A5 JP 2025160226A5 JP 2025114854 A JP2025114854 A JP 2025114854A JP 2025114854 A JP2025114854 A JP 2025114854A JP 2025160226 A5 JP2025160226 A5 JP 2025160226A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- heterodimeric protein
- polypeptide
- residue
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2020/073960 | 2020-01-23 | ||
| CN2020073960 | 2020-01-23 | ||
| JP2022544309A JP7710450B2 (ja) | 2020-01-23 | 2021-01-22 | Ｆｃ変異を有するヘテロダイマータンパク質 |
| PCT/CN2021/073347 WO2021148006A1 (en) | 2020-01-23 | 2021-01-22 | Heterodimeric proteins with fc mutations |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022544309A Division JP7710450B2 (ja) | 2020-01-23 | 2021-01-22 | Ｆｃ変異を有するヘテロダイマータンパク質 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025160226A JP2025160226A (ja) | 2025-10-22 |
| JP2025160226A5 true JP2025160226A5 (https=) | 2026-03-11 |
Family
ID=76992067
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022544309A Active JP7710450B2 (ja) | 2020-01-23 | 2021-01-22 | Ｆｃ変異を有するヘテロダイマータンパク質 |
| JP2025114854A Pending JP2025160226A (ja) | 2020-01-23 | 2025-07-08 | Ｆｃ変異を有するヘテロダイマータンパク質 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022544309A Active JP7710450B2 (ja) | 2020-01-23 | 2021-01-22 | Ｆｃ変異を有するヘテロダイマータンパク質 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230124669A1 (https=) |
| EP (1) | EP4093778A4 (https=) |
| JP (2) | JP7710450B2 (https=) |
| KR (1) | KR20220145833A (https=) |
| CN (1) | CN115279796A (https=) |
| AU (1) | AU2021210482A1 (https=) |
| BR (1) | BR112022014574A2 (https=) |
| CA (1) | CA3165045A1 (https=) |
| IL (1) | IL294878A (https=) |
| MX (1) | MX2022009101A (https=) |
| WO (1) | WO2021148006A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022170619A1 (en) * | 2021-02-11 | 2022-08-18 | Adagene Pte. Ltd. | Anti-cd3 antibodies and methods of use thereof |
| US12441816B2 (en) | 2021-09-21 | 2025-10-14 | Qilu Puget Sound Biotherapeutics Corporation | Heterodimeric Fc for making fusion proteins and bispecific antibodies |
| US20250333539A1 (en) * | 2022-03-23 | 2025-10-30 | Cytomx Therapeutics, Inc. | Activatable antigen-binding protein constructs and uses of the same |
| WO2023193239A1 (en) | 2022-04-08 | 2023-10-12 | Peter Peizhi Luo | Anti-cd28 antibodies and methods of use thereof |
| CN121666401A (zh) * | 2023-07-10 | 2026-03-13 | 瑞泽恩制药公司 | 双特异性PD-L1x4-1BB抗体及其使用方法 |
| TW202528360A (zh) * | 2023-11-20 | 2025-07-16 | 大陸商江蘇恆瑞醫藥股份有限公司 | 藉由重組反應製備異源多聚體的方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1791565T3 (en) * | 2004-09-23 | 2016-08-01 | Genentech Inc | Cysteingensplejsede antibodies and conjugates |
| US8054928B2 (en) * | 2005-11-14 | 2011-11-08 | Ati Technologies, Inc. | Programmable preamble system and method |
| RU2636046C2 (ru) * | 2009-01-12 | 2017-11-17 | Сайтомкс Терапьютикс, Инк | Композиции модифицированных антител, способы их получения и применения |
| WO2011028952A1 (en) * | 2009-09-02 | 2011-03-10 | Xencor, Inc. | Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens |
| CA2785907A1 (en) * | 2009-12-29 | 2011-07-28 | Emergent Product Development Seattle, Llc | Ron binding constructs and methods of use thereof |
| EP2576621B1 (en) * | 2010-05-27 | 2019-04-10 | Genmab A/S | Monoclonal antibodies against her2 |
| SG11201401422VA (en) * | 2011-10-27 | 2014-09-26 | Genmab As | Production of heterodimeric proteins |
| WO2013118722A1 (ja) * | 2012-02-06 | 2013-08-15 | トヨタ自動車株式会社 | 硫化物固体電解質材料、電池および硫化物固体電解質材料の製造方法 |
| UY35148A (es) * | 2012-11-21 | 2014-05-30 | Amgen Inc | Immunoglobulinas heterodiméricas |
| JP6594855B2 (ja) * | 2013-03-15 | 2019-10-23 | ゼンコア インコーポレイテッド | ヘテロ二量体タンパク質 |
| JP2016538275A (ja) * | 2013-11-04 | 2016-12-08 | グレンマーク ファーマシューティカルズ， エセ．アー． | Ｔ細胞再標的化ヘテロ二量体免疫グロブリン（ｈｅｔｅｒｏ−ｄｉｍｅｒｉｃ ｉｍｍｕｎｏｇｌｏｂｕｌｉｎ）の製造 |
| US20160176969A1 (en) * | 2014-11-26 | 2016-06-23 | Xencor, Inc. | Heterodimeric antibodies including binding to cd8 |
| EP3227332B1 (en) * | 2014-12-03 | 2019-11-06 | F.Hoffmann-La Roche Ag | Multispecific antibodies |
| CN107408987B (zh) * | 2015-03-20 | 2020-03-17 | 日本电气株式会社 | 可插拔光模块、光通信系统和可插拔光模块控制方法 |
| CN106883297B (zh) * | 2015-12-16 | 2019-12-13 | 苏州康宁杰瑞生物科技有限公司 | 基于ch3结构域的异二聚体分子、其制备方法及用途 |
| EP3489262A4 (en) * | 2016-07-19 | 2020-07-08 | Ibentrus, Inc. | BISPECIFIC PROTEINS AND PROCESSES FOR THEIR PREPARATION |
| WO2019014912A1 (zh) * | 2017-07-21 | 2019-01-24 | 赵磊 | 一种异二聚体蛋白及其制备方法 |
| AU2018393111B2 (en) * | 2017-12-21 | 2025-07-10 | Amunix Pharmaceuticals, Inc. | Release segments and binding compositions comprising same |
| WO2019148445A1 (en) * | 2018-02-02 | 2019-08-08 | Adagene Inc. | Precision/context-dependent activatable antibodies, and methods of making and using the same |
| TWI798601B (zh) * | 2020-11-27 | 2023-04-11 | 晶睿通訊股份有限公司 | 地面起伏偵測方法及其監控攝影機 |
| JP7295438B2 (ja) * | 2020-11-30 | 2023-06-21 | 日亜化学工業株式会社 | 面状光源 |
| WO2023193239A1 (en) * | 2022-04-08 | 2023-10-12 | Peter Peizhi Luo | Anti-cd28 antibodies and methods of use thereof |
-
2021
- 2021-01-22 CN CN202180021100.0A patent/CN115279796A/zh active Pending
- 2021-01-22 MX MX2022009101A patent/MX2022009101A/es unknown
- 2021-01-22 US US17/759,282 patent/US20230124669A1/en active Pending
- 2021-01-22 CA CA3165045A patent/CA3165045A1/en active Pending
- 2021-01-22 JP JP2022544309A patent/JP7710450B2/ja active Active
- 2021-01-22 WO PCT/CN2021/073347 patent/WO2021148006A1/en not_active Ceased
- 2021-01-22 EP EP21744991.7A patent/EP4093778A4/en active Pending
- 2021-01-22 KR KR1020227029071A patent/KR20220145833A/ko active Pending
- 2021-01-22 AU AU2021210482A patent/AU2021210482A1/en active Pending
- 2021-01-22 IL IL294878A patent/IL294878A/en unknown
- 2021-01-22 BR BR112022014574A patent/BR112022014574A2/pt unknown
-
2025
- 2025-07-08 JP JP2025114854A patent/JP2025160226A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025160226A5 (https=) | ||
| JP2023511376A5 (https=) | ||
| AU2012236603B2 (en) | Dual variable region antibody-like binding proteins having cross-over binding region orientation | |
| JP5719354B2 (ja) | 三重又は四重特異性抗体 | |
| JP2023178323A5 (https=) | ||
| IL272747B2 (en) | Bispecific antibodies 1 + 2 | |
| JP2024508671A5 (https=) | ||
| JP2021503455A5 (https=) | ||
| AU2010230563A1 (en) | Multispecific antibodies comprising full length antibodies and single chain Fab fragments | |
| JP2023516004A5 (https=) | ||
| IL276903B1 (en) | Bispecific egfr/cd16 antigen-binding protein | |
| WO2013064701A2 (en) | Bispecific antibodies and methods for isolating same | |
| JP2022545647A5 (https=) | ||
| JP2021520832A5 (https=) | ||
| JP2025063183A5 (https=) | ||
| JP2023548529A5 (https=) | ||
| JP2023549555A5 (https=) | ||
| JP2023516941A5 (https=) | ||
| US20180371088A1 (en) | TARGET CELL-DEPENDENT T CELL ENGAGING AND ACTIVATION ASYMMETRIC HETERODIMERIC Fc-ScFv FUSION ANTIBODY FORMAT AND USES THEREOF IN CANCER THERAPY | |
| JPWO2022102768A5 (https=) | ||
| JP2024542235A5 (https=) | ||
| US20250277055A1 (en) | Bi- or multi-specific antibody | |
| KR20260015834A (ko) | Ch3 도메인 변이체 또는 이를 포함하는 이중 특이적 항체 | |
| WO2024061224A1 (zh) | 抗her2抗体及其用途 | |
| JP2024543828A5 (https=) |